President and CEO
Olivier Visa was named President and Chief Executive Officer of RTI Surgical in July 2020. He is now leading the development and strategic execution of RTI Surgical toward accelerated growth, enhanced employee development, patient-centric innovation, and customer intimacy.
Having joined RTI in 2017 as OEM Franchise leader, Visa brings more than 28 years of life sciences leadership experience to the team and is highly regarded for driving focus on patient outcomes and team collaboration to lead dynamic business transformation and build sustainable value. Prior to joining RTI, as Vice President of the Global Compounding business unit of Baxter Healthcare, Visa led, with the support of the country leaders, the acceleration of profitable growth with a relentless focus on patient safety. Prior to this role, he had multiple commercial leadership responsibilities across the world, including Baxter Pharmaceuticals and Technology as well as its global contract manufacturing business.
Visa earned a doctorate degree in pharmacy from the University of Aix Marseille II and a Master of Business Administration from the Kellogg School of Management at Northwestern University.